Loading quotes...

Forecast

The analysts' average price target is €108.68 (-2.35%). The median is €109.72 (-1.42%).

Buy
  9
Hold
  18
Sell
  5

  • Aflac prioritizes human empathy over AI for sensitive customer interactions

    Aflac says AI and automation should handle routine transactions, but human agents are essential for sensitive health-related calls where empathy matters. Keith Farley, Aflac’s chief customer officer, emphasizes hiring for authentic empathy rather than trying to train it, and leaders should "walk the process" to experience customer journeys firsthand. The company advocates balancing efficiency gains from AI with easy access to humans for reassurance and complex issues. » More on forbes.com


  • Aflac viewed as steady but unspectacular by Jim Cramer

    Jim Cramer characterized Aflac as "not great, not bad," reflecting a low-risk, low-growth profile. In Q2 Aflac reported net earnings of $825 million versus $599 million a year earlier, while total revenues fell to $4.1 billion amid foreign-exchange headwinds and weaker yen-driven results in Japan. Management returned $1.3 billion in capital through $983 million of buybacks and $309 million of dividends, supporting a long history of dividend increases. Revenue and adjusted earnings were pressured by currency translation, leaving upside limited but downside contained. » More on finance.yahoo.com


  • Aflac uses high‑yield environment in Japan to reposition portfolio and drive growth

    At the KBW Insurance Conference 2026, Aflac presented a strategy of capital discipline, selective growth and operational improvements. The company repositioned roughly 5% of its Japan portfolio, boosting net investment income and reducing valuation risks, while savings and life products and the new reinsurance offering Aflac Re are providing growth. In the US, Aflac is selectively expanding group and direct business as well as dental and vision benefits, but expects significant scale effects only in 2–3 years. AI is expected to deliver efficiency gains, but is not seen as the primary lever to lower expense ratios; the capital position remains comfortably above target levels. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2026, AFLAC has already paid €1.57 in dividends. The last payout was in September.

Financials

In the last quarter, AFLAC had revenue of €3.58B and net profit of €722.87M
(EUR) June 2026
YoY
Revenue 3.58B 0.03%
Gross profit 1.95B 94.77%
Net profit 722.87M 42.24%
EBITDA 1.13B 61.45%

Fundamentals

Metric Value
Market capitalization
€55.18B
Number of shares
501.34M
52-week high/low
€115.69 - €93.71
Dividend yield
1.87%
Dividends TTM
€2.07
Beta
0.56
P/E ratio
13.29
PEG ratio
0.12
P/B ratio
2.06
P/S ratio
3.43

Company profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.

Name
AFLAC
CEO
Daniel Paul Amos
Headquarters Columbus, ga
USA
Website
Sector
Financials
Industry
Insurance
IPO
03/17/1980
Employees 12,716

Ticker symbols

Exchange Symbol
NYSE
AFL
London Stock Exchange
0H68.L
XETRA
AFL.DE
Frankfurt
AFL.F
Düsseldorf
AFL.DU
Hamburg
AFL.HM
London
0H68.L
SIX
AFL.SW
München
AFL.MU
Wien
AFL.VI
🍪

Parqet  uses cookies. Learn more